Marked cerebral atrophy is correlated with kidney dysfunction in nondisabled adults

The relationship between kidney dysfunction, such as chronic kidney disease (CKD), and brain morphology has attracted increasing attention, but the association between kidney dysfunction and cerebral atrophy has yet to be determined. The purpose of this study was to clarify the relationship between kidney function and a substantial degree of cerebral atrophy. A total of 610 consecutive Japanese adults without neurological disorders who had undergone health screening tests of the brain were studied prospectively. Magnetic resonance imaging was performed using a 1.5-T scanner. Using a computer-assisted processing system, the percentage of cerebrum atrophy (%Cerebrum atrophy) was calculated as an index of cerebral atrophy. Atrophy was defined as >2 s.d.s below the mean %Cerebrum atrophy. The glomerular filtration rate (GFR) was estimated using the revised equations for estimated GFR from serum creatinine in Japan. Kidney function variables included the GFR value and the prevalence of subjects with GFR <60 ml min−1 per 1.73 m2. Cerebral atrophy was found in 25 (4.1%) cases. Univariate analysis showed that age, male sex, hypertension, each kidney function variable, white matter hyperintensities and lacunae were associated with cerebral atrophy. On logistic regression analysis, GFR (odds ratio (OR), 0.64; 95% confidence interval (CI), 0.42–0.98) and GFR <60 ml min−1 per 1.73 m2 (OR, 5.93; 95% CI, 1.82–19.27) were significantly associated with cerebral atrophy. On sub-analysis, GFR <60 ml min−1 per 1.73 m2 was significantly associated with cortical atrophy (OR, 3.23; 95% CI, 1.15–9.11). Decreased GFR was significantly associated with cerebral atrophy, indicating that treatment of CKD may control age-related degenerative processes of the brain.

[1]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[2]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[3]  L. Kuller,et al.  Statins and cognitive function in the elderly , 2005, Neurology.

[4]  R. Toto,et al.  Slowing chronic kidney disease progression: results of prospective clinical trials in adults , 2008, Pediatric Nephrology.

[5]  C. DeCarli,et al.  Chronic Kidney Disease Is Associated With White Matter Hyperintensity Volume: The Northern Manhattan Study (NOMAS) , 2007, Stroke.

[6]  Carole Dufouil,et al.  Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. , 2004, Diabetes.

[7]  H. Bokura,et al.  Subcortical silent brain infarction as a risk factor for clinical stroke. , 1997, Stroke.

[8]  Wiro J Niessen,et al.  Kidney Function Is Related to Cerebral Small Vessel Disease , 2008, Stroke.

[9]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[10]  E. B. Larson,et al.  Statin Therapy Is Associated with Reduced Neuropathologic Changes Statin Therapy Is Associated with Reduced Neuropathologic Changes of Alzheimer Disease , 2022 .

[11]  P. Stenvinkel,et al.  CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Homocysteine‐Lowering Is Not a Primary Target for Cardiovascular Disease Prevention in Chronic Kidney Disease Patients , 2007, Seminars in dialysis.

[12]  Gary A. Ford,et al.  Brain atrophy and white matter hyperintensity change in older adults and relationship to blood pressure , 2007, Journal of Neurology.

[13]  Michael F O'Rourke,et al.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. , 2005, Hypertension.

[14]  S. Levine,et al.  Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects , 2002, Journal of neurology, neurosurgery, and psychiatry.

[15]  Takeo Kato,et al.  Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects , 2007, Journal of the Neurological Sciences.

[16]  L. Fried,et al.  Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. , 1998, Stroke.

[17]  L. Allegri,et al.  Hypertension as an Etiopathological Factor in the Development of Cerebral Atrophy in Hemodialyzed Patients , 1999, Nephron.

[18]  Y. Nanri,et al.  Brain Microbleeds and Global Cognitive Function in Adults Without Neurological Disorder , 2008, Stroke.

[19]  C. Thompson,et al.  Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. , 2009, Stroke.

[20]  A Hofman,et al.  Homocysteine and brain atrophy on MRI of non-demented elderly. , 2003, Brain : a journal of neurology.

[21]  P. Matthews,et al.  Risk factors for progression of brain atrophy in aging , 2005, Neurology.

[22]  R B D'Agostino,et al.  Stroke risk profile, brain volume, and cognitive function , 2004, Neurology.

[23]  Charles E. McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[24]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Nick Bryan,et al.  Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.

[26]  G. Alexander,et al.  Interactive effects of age and hypertension on volumes of brain structures. , 1997, Stroke.

[27]  M. Woodward,et al.  Effects of Blood Pressure Lowering on Cerebral White Matter Hyperintensities in Patients With Stroke: The PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy , 2005, Circulation.

[28]  Deeb N Salem,et al.  Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. , 2003, Journal of the American College of Cardiology.

[29]  C. Jack,et al.  Associations of microalbuminuria with brain atrophy and white matter hyperintensities in hypertensive sibships , 2008, Journal of the Neurological Sciences.

[30]  P. Sandercock,et al.  Is Breakdown of the Blood-Brain Barrier Responsible for Lacunar Stroke, Leukoaraiosis, and Dementia? , 2003, Stroke.

[31]  Anne Newman,et al.  Cystatin C and subclinical brain infarction. , 2005, Journal of the American Society of Nephrology : JASN.

[32]  D. Siscovick,et al.  Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older Adults: The Cardiovascular Health Study , 2001, Stroke.

[33]  J. Spence Preventing dementia by treating hypertension and preventing stroke. , 2004, Hypertension.

[34]  G. Ratcliff,et al.  Sex differences in brain aging: a quantitative magnetic resonance imaging study. , 1998, Archives of neurology.

[35]  T. Ohtake,et al.  Asymptomatic cerebral lacunae in patients with chronic kidney disease. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  Albert Hofman,et al.  Cognitive Correlates of Ventricular Enlargement and Cerebral White Matter Lesions on Magnetic Resonance Imaging: The Rotterdam Study , 1994, Stroke.

[37]  H. Kraemer,et al.  Ethnic and Socioeconomic Differences in Cardiovascular Disease Risk Factors: Findings for Women From the Third National Health and Nutrition Examination Survey, 1988-1994 , 1999 .

[38]  Jiang He,et al.  Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. , 2002, Journal of the American Society of Nephrology : JASN.

[39]  Yasuo Terayama,et al.  Risk factors accelerating cerebral degenerative changes, cognitive decline and dementia , 1999, International journal of geriatric psychiatry.